{"database": "lobbying", "table": "lobbying_activities", "rows": [[2179869, "aab48ac7-57ba-4eba-8297-26b8c4333b7a", "Q3", "AMERICAN CAPITOL GROUP", 305852, "THE CORMAC GROUP, ON BEHALF OF GENOMEDX", 2018, "third_quarter", "HCR", "coverage of prostate cancer testing", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2018-10-03T16:17:04.460000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2179869"], "units": {}, "query_ms": 5.929417093284428, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}